Transcatheter Valve Replacement in Carcinoid Heart Disease: A Potential Change of Paradigm
This first series of transcatheter valve replacements in carcinoid heart disease suggests that a complete percutaneous approach is feasible, safe, and potentially beneficial. These early results warrant confirmation in larger cohorts with longer follow-up and may represent a paradigm shift in the management of carcinoid valve disease.
Authors
- Mariette Barbier (ORCID: https://orcid.org/0000-0002-3250-3636)
- Laura Gérard (ORCID: https://orcid.org/0009-0005-9369-6389)
- Obadia Jf
- Laurent François
- Gilles Rioufol
- Thomas Walter
Institutions
- Hospices Civils de Lyon (FR)
- Hôpital Louis Pradel (FR)
Publication Details
- Journal
- Interdisciplinary CardioVascular and Thoracic Surgery
- Published
- 2026-01-01
- DOI
- https://doi.org/10.1093/icvts/ivag001
- Primary Topic
- Neuroendocrine Tumor Research Advances
- Type
- article
- Field-Weighted Citation Impact
- 0.00